scAtria single-cell spatial atlas resource

NSCLC_38242124 · IMC / Imaging Mass Cytometry

NSCLC_38242124 · NSCLC_38242124__IMC

IMC / Imaging Mass Cytometry Spatial proteomics Curated Tiered

Interaction Propensity

Download spatial tables

Interaction Propensity (Tier 1)

2,069 ready
Sample Organ Disease state Cells Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. Direction Propensity FDR
NSCLC_38242124__IMC__175_B1,16 Lung Primary cancer 2,528 Tumor/Malignant -> Tumor/Malignant Enriched 3.38 1.44e-2
NSCLC_38242124__IMC__175_B1,17 Lung Primary cancer 1,429 Tumor/Malignant -> Tumor/Malignant Enriched 4.23 1.32e-2
NSCLC_38242124__IMC__175_B1,2 Lung Primary cancer 2,305 Tumor/Malignant -> Tumor/Malignant Enriched 4.25 1.32e-2
NSCLC_38242124__IMC__175_B1,3 Lung Primary cancer 4,171 Tumor/Malignant -> Tumor/Malignant Enriched 5.55 9.90e-3
NSCLC_38242124__IMC__175_B1,4 Lung Primary cancer 2,713 Tumor/Malignant -> Tumor/Malignant Enriched 4.90 1.06e-2
NSCLC_38242124__IMC__175_B1,5 Lung Primary cancer 3,623 Tumor/Malignant -> Tumor/Malignant Enriched 4.91 1.22e-2
NSCLC_38242124__IMC__175_B1,6 Lung Primary cancer 3,146 Tumor/Malignant -> Tumor/Malignant Enriched 4.04 1.06e-2
NSCLC_38242124__IMC__175_B1,7 Lung Primary cancer 3,665 Tumor/Malignant -> Tumor/Malignant Enriched 5.68 1.13e-2
NSCLC_38242124__IMC__175_B1,8 Lung Primary cancer 2,860 Tumor/Malignant -> Tumor/Malignant Enriched 4.87 1.22e-2
NSCLC_38242124__IMC__175_B1,9 Lung Primary cancer 4,697 Tumor/Malignant -> Tumor/Malignant Enriched 5.38 1.06e-2
NSCLC_38242124__IMC__175_B2,1 Lung Primary cancer 2,353 Tumor/Malignant -> Tumor/Malignant Enriched 5.01 1.32e-2
NSCLC_38242124__IMC__175_B2,10 Lung Primary cancer 2,177 Tumor/Malignant -> Tumor/Malignant Enriched 4.08 1.22e-2
NSCLC_38242124__IMC__175_B2,11 Lung Primary cancer 3,015 Tumor/Malignant -> Tumor/Malignant Enriched 4.21 1.13e-2
NSCLC_38242124__IMC__175_B2,12 Lung Primary cancer 2,539 Tumor/Malignant -> Tumor/Malignant Enriched 4.47 9.90e-3
NSCLC_38242124__IMC__175_B2,13 Lung Primary cancer 3,504 Tumor/Malignant -> Tumor/Malignant Enriched 4.67 1.06e-2
NSCLC_38242124__IMC__175_B2,14 Lung Primary cancer 2,748 Tumor/Malignant -> Tumor/Malignant Enriched 5.56 1.58e-2
NSCLC_38242124__IMC__175_B2,15 Lung Primary cancer 3,020 Tumor/Malignant -> Tumor/Malignant Enriched 3.98 1.32e-2
NSCLC_38242124__IMC__175_B2,16 Lung Primary cancer 3,084 Tumor/Malignant -> Tumor/Malignant Enriched 3.97 1.13e-2
NSCLC_38242124__IMC__175_B2,17 Lung Primary cancer 2,285 Stromal -> Stromal Enriched 3.91 1.44e-2
NSCLC_38242124__IMC__175_B2,2 Lung Primary cancer 1,910 Immune -> Stromal Enriched 4.38 2.26e-2

Interaction Propensity (Tier 2)

2,069 ready
Sample Organ Disease state Cells Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. Direction Propensity FDR
NSCLC_38242124__IMC__175_B1,16 Lung Primary cancer 2,528 Tumor/Malignant -> Tumor/Malignant Enriched 3.38 2.25e-2
NSCLC_38242124__IMC__175_B1,17 Lung Primary cancer 1,429 Tumor/Malignant -> Tumor/Malignant Enriched 4.23 1.55e-2
NSCLC_38242124__IMC__175_B1,2 Lung Primary cancer 2,305 Lymphoid -> Stromal Enriched 5.00 1.65e-2
NSCLC_38242124__IMC__175_B1,3 Lung Primary cancer 4,171 Tumor/Malignant -> Tumor/Malignant Enriched 5.55 1.13e-2
NSCLC_38242124__IMC__175_B1,4 Lung Primary cancer 2,713 Tumor/Malignant -> Tumor/Malignant Enriched 4.90 1.46e-2
NSCLC_38242124__IMC__175_B1,5 Lung Primary cancer 3,623 Tumor/Malignant -> Tumor/Malignant Enriched 4.91 1.24e-2
NSCLC_38242124__IMC__175_B1,6 Lung Primary cancer 3,146 Tumor/Malignant -> Tumor/Malignant Enriched 4.04 1.13e-2
NSCLC_38242124__IMC__175_B1,7 Lung Primary cancer 3,665 Tumor/Malignant -> Tumor/Malignant Enriched 5.68 1.13e-2
NSCLC_38242124__IMC__175_B1,8 Lung Primary cancer 2,860 Tumor/Malignant -> Tumor/Malignant Enriched 4.87 1.46e-2
NSCLC_38242124__IMC__175_B1,9 Lung Primary cancer 4,697 Tumor/Malignant -> Tumor/Malignant Enriched 5.38 1.46e-2
NSCLC_38242124__IMC__175_B2,1 Lung Primary cancer 2,353 Tumor/Malignant -> Tumor/Malignant Enriched 5.01 1.55e-2
NSCLC_38242124__IMC__175_B2,10 Lung Primary cancer 2,177 Tumor/Malignant -> Tumor/Malignant Enriched 4.08 1.38e-2
NSCLC_38242124__IMC__175_B2,11 Lung Primary cancer 3,015 Tumor/Malignant -> Tumor/Malignant Enriched 4.21 1.13e-2
NSCLC_38242124__IMC__175_B2,12 Lung Primary cancer 2,539 Tumor/Malignant -> Tumor/Malignant Enriched 4.47 1.24e-2
NSCLC_38242124__IMC__175_B2,13 Lung Primary cancer 3,504 Tumor/Malignant -> Tumor/Malignant Enriched 4.67 1.55e-2
NSCLC_38242124__IMC__175_B2,14 Lung Primary cancer 2,748 Tumor/Malignant -> Tumor/Malignant Enriched 5.56 2.25e-2
NSCLC_38242124__IMC__175_B2,15 Lung Primary cancer 3,020 Tumor/Malignant -> Tumor/Malignant Enriched 3.98 1.46e-2
NSCLC_38242124__IMC__175_B2,16 Lung Primary cancer 3,084 Tumor/Malignant -> Tumor/Malignant Enriched 3.97 1.18e-2
NSCLC_38242124__IMC__175_B2,17 Lung Primary cancer 2,285 Stromal -> Stromal Enriched 3.91 1.55e-2
NSCLC_38242124__IMC__175_B2,2 Lung Primary cancer 1,910 Lymphoid -> Stromal Enriched 4.50 2.75e-2

Interaction Propensity (Tier 3)

2,069 ready
Sample Organ Disease state Cells Strongest directed pair ?Tier 1 from-label to to-label pair with the largest departure from neutral propensity among enriched/depleted contacts. Direction Propensity FDR
NSCLC_38242124__IMC__175_B1,16 Lung Primary cancer 2,528 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 3.38 4.85e-2
NSCLC_38242124__IMC__175_B1,17 Lung Primary cancer 1,429 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.23 2.19e-2
NSCLC_38242124__IMC__175_B1,2 Lung Primary cancer 2,305 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.25 2.55e-2
NSCLC_38242124__IMC__175_B1,3 Lung Primary cancer 4,171 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.55 1.86e-2
NSCLC_38242124__IMC__175_B1,4 Lung Primary cancer 2,713 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.90 2.35e-2
NSCLC_38242124__IMC__175_B1,5 Lung Primary cancer 3,623 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.91 2.76e-2
NSCLC_38242124__IMC__175_B1,6 Lung Primary cancer 3,146 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.04 2.26e-2
NSCLC_38242124__IMC__175_B1,7 Lung Primary cancer 3,665 B cell -> Tumor/Malignant cell Enriched 6.00 1.73e-2
NSCLC_38242124__IMC__175_B1,8 Lung Primary cancer 2,860 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.87 2.53e-2
NSCLC_38242124__IMC__175_B1,9 Lung Primary cancer 4,697 Granulocyte -> T cell Enriched 5.50 2.02e-2
NSCLC_38242124__IMC__175_B2,1 Lung Primary cancer 2,353 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.01 3.02e-2
NSCLC_38242124__IMC__175_B2,10 Lung Primary cancer 2,177 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.08 3.34e-2
NSCLC_38242124__IMC__175_B2,11 Lung Primary cancer 3,015 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.21 2.35e-2
NSCLC_38242124__IMC__175_B2,12 Lung Primary cancer 2,539 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.47 2.44e-2
NSCLC_38242124__IMC__175_B2,13 Lung Primary cancer 3,504 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 4.67 3.17e-2
NSCLC_38242124__IMC__175_B2,14 Lung Primary cancer 2,748 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 5.56 3.03e-2
NSCLC_38242124__IMC__175_B2,15 Lung Primary cancer 3,020 Granulocyte -> T cell Enriched 4.00 2.35e-2
NSCLC_38242124__IMC__175_B2,16 Lung Primary cancer 3,084 Tumor/Malignant cell -> Tumor/Malignant cell Enriched 3.97 1.67e-2
NSCLC_38242124__IMC__175_B2,17 Lung Primary cancer 2,285 Fibroblast -> Fibroblast Enriched 3.48 2.76e-2
NSCLC_38242124__IMC__175_B2,2 Lung Primary cancer 1,910 T cell -> Fibroblast Enriched 4.25 4.04e-2